Frankfurt - Delayed Quote EUR

Outlook Therapeutics, Inc. (41O.F)

Compare
2.0600
+0.0200
+(0.98%)
At close: January 10 at 3:29:01 PM GMT+1
All numbers in thousands
Breakdown
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Assets
28,823.1540
32,300.6010
28,527.7510
22,811.4510
Total Liabilities Net Minority Interest
101,899.6640
46,738.3780
19,791.1800
18,204.0020
Total Equity Gross Minority Interest
-73,076.5100
-14,437.7770
8,736.5710
4,607.4490
Total Capitalization
-73,076.5100
-14,437.7770
8,736.5710
15,493.3030
Common Stock Equity
-73,076.5100
-14,437.7770
8,736.5710
4,607.4490
Capital Lease Obligations
297.8290
4.2670
43.0130
112.3310
Net Tangible Assets
-73,076.5100
-14,437.7770
8,736.5710
4,607.4490
Working Capital
-15,137.6930
-15,752.9610
7,790.6710
14,755.9300
Invested Capital
-43,636.5100
21,113.2230
19,651.5860
16,397.5030
Tangible Book Value
-73,076.5100
-14,437.7770
8,736.5710
4,607.4490
Total Debt
29,737.8290
35,555.2670
10,958.0280
11,902.3850
Net Debt
14,512.4620
12,159.0180
--
--
Share Issued
23,905.6350
13,012.8750
11,365.5280
8,823.0810
Ordinary Shares Number
23,905.6350
13,012.8750
11,365.5280
8,823.0810
9/30/2021 - 5/21/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers